Construction, Selection and Immunogenicity of Recombinant Fowlpox Candidate Vaccine Co-expressing HIV-1 gag and gp145
Sign Up to like & getrecommendations! Published in 2017 at "Indian Journal of Microbiology"
DOI: 10.1007/s12088-017-0639-3
Abstract: An HIV candidate vaccine for the Chinese population was designed by constructing a recombinant fowlpox virus expressing HIV-1 gag and HIV gp145 proteins via homologous recombination and plaque screening using enhanced green fluorescent protein (EGFP)… read more here.
Keywords: recombinant fowlpox; candidate vaccine; expressing hiv; hiv gag ... See more keywords
Homologous PB1 gene promotes the replication efficiency of avian influenza H7N4 candidate vaccine virus
Sign Up to like & getrecommendations! Published in 2022 at "Influenza and Other Respiratory Viruses"
DOI: 10.1111/irv.12954
Abstract: The first and only case of human infection with the avian influenza A (H7N4) virus in China emerged in 2018. The H7N4 virus was distinct from previous H7N9 viruses and raised public concerns. Therefore, developing… read more here.
Keywords: h7n4 candidate; influenza; influenza h7n4; avian influenza ... See more keywords
A multi-epitope fusion antigen candidate vaccine for Enterotoxigenic Escherichia coli is protective against strain B7A colonization in a rabbit model
Sign Up to like & getrecommendations! Published in 2022 at "PLoS Neglected Tropical Diseases"
DOI: 10.1371/journal.pntd.0010177
Abstract: Enterotoxigenic Escherichia coli (ETEC) strains are a leading cause of children’s and travelers’ diarrhea. Developing effective vaccines against this heterologous group has proven difficult due to the varied nature of toxins and adhesins that determine… read more here.
Keywords: antigen; colonization; enterotoxigenic escherichia; candidate vaccine ... See more keywords
Development of an Integrated Continuous Manufacturing Process for the rVSV-Vectored SARS-CoV-2 Candidate Vaccine
Sign Up to like & getrecommendations! Published in 2023 at "Vaccines"
DOI: 10.3390/vaccines11040841
Abstract: The administration of viral vectored vaccines remains one of the most effective ways to respond to the ongoing novel coronavirus disease 2019 (COVID-19) pandemic. However, pre-existing immunity to the viral vector hinders its potency, resulting… read more here.
Keywords: manufacturing process; rvsv; sars cov; candidate vaccine ... See more keywords